ランチョン

2017年10月13日(金) 12:00-13:00

アネックス
ホール
F203

英語進行

【L-7】 Metabolon

Precision Metabolomics™ Illuminates New Paths for Medicine and Pharmaceutical R&D

The post-genome ear has led to new targets and precision medicine solutions but has also revealed staggering complexity. In response to this complexity, there is an escalation in the scale of next-generation sequencing initiatives, but also, a realization that complementary or alternative technologies are required. Technologies that provides a comprehensive, physiologically meaningful assessment and link to how a drug or disease affects a patient are key. This is what metabolomics does. Through its unique approach, Metabolon's Precision Metabolomics™ technology is proving to be a key ally for precision medicine and pharmaceutical R&D.

Precision Metabolomics™ Illuminates New Paths for Medicine and Pharmaceutical R&D

Kirk Beebe

Sr. Director, Applied Metabolomics Metabolon

このウィンドウを閉じる